SERPINF1 and ovarian hyperstimulation syndrome: The findings reported above suggest that letrozole could decrease the risk of OHSS although it is not clear if the effect on VEGF and PEDF secretion is a direct action of letrozole or an indirect effect through a reduction in estradiol levels.